Live Breaking News & Updates on Martina Brueckmann

Stay updated with breaking news from Martina brueckmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial

Germany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and increased mortality, the researchers state in a study. ....

Pedro Ferreira , Augustenburger Platz , Carolyn Kaempfer , Milton Packer , Afshin Salsali , Jamesl Januzzi , Wolfram Doehner , Gerasimos Filippatos , Martina Brueckmann , Faiez Zannad , Javed Butler , Stuartj Pocock , Stefand Anker , Berlin Institute Of Health Center , European Heart , Berlin Institute , Health Center , Regenerative Therapies , European Heart Journal , Heart Failure , Reduced Ejection Fraction , Uric Acid , Disease Severity , Sglt2 Inhibitor , Mperor Reduced Trial ,

Adults With Acute Heart Failure Benefit When Treated With a Type 2 Diabetes Medication

EMPULSE Trial showed hospitalized adults taking empagliflozin had reduced rates of death or re-hospitalization due to acute heart failure ....

United States , Pedro Ferreira , Johnr Teerlink , Mitchell Psotka , Jonp Blatchford , Afshin Salsali , Martina Brueckmann , Christianee Angermann , Adriaan Voors , Piotr Ponikowski , Michaele Nassif , Mikhailn Kosiborod , Jan Biegas , Seanp Collins , Eli Lilly Company , Boehringer Ingelheim , American Heart Association Scientific Sessions , University Medical Centre Groningen , American Heart Association , Scientific Sessions , Hospitalized Heart Failure Patients , Main Results , Kansas City Cardiomyopathy Questionnaire , Jasper Tromp , Eli Lilly ,